One Roxicet product (5/325 mg tablets) is considered a generic version of Percocet. However, the Roxicet 5/500 mg caplets and 5/325 mg oral solution are considered brand-name products. Although there are no patents prohibiting generic versions of these products, there are no generic Roxicet caplets or oral solution at this time. It is not known when or if a company will choose to manufacture any of these generics.
Roxicet is made by Roxane Laboratories, Inc. One Roxicet product is actually a generic medication, while the other two are brand-name products.
Availability of Generic Roxicet
Roxicet 5/325 mg tablets are actually generic for Percocet. Instead of using the standard "generic name," the manufacturer chose to create a new name ("Roxicet"). The Roxicet 5/500 mg caplets and 5/325 mg oral solution (liquid) are considered brand-name products. At this time no generic Roxicet 5/500 mg caplets are available, although generic oxycodone/APAP 5/500 capsules, equivalent to Tylox®, are available (these products are very similar, but technically not equivalent to Roxicet). Roxicet oral solution is not available in generic form.
There are no unexpired patents for Roxicet (which means another company could make a generic version of Roxicet 5/500 caplets or oral solution at any time). However, it is difficult to predict when or if another company will ever decide to do so.
Why Did I Get Roxicet Instead of Percocet?
If your healthcare provider wrote you a prescription for Percocet 5/325 tablets, a pharmacist may substitute Roxicet 5/325 tablets in most states. The United States Food and Drug Administration (FDA) has determined that these two products are equivalent. Most insurance companies require your pharmacist to dispense a generic medication if one is available. Some insurance companies may cover a brand-name product (even if a generic is available) if your healthcare provider writes, "Do not substitute" or "Brand-name medically necessary" (or something similar) on your prescription, although this is generally not the case.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed September 2, 2008.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click